Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong · Delayed Price · Currency is HKD 2.650
+0.260 (10.88%)
Sep 11, 2026, 4:08 PM HKT
HKG:2427 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,271 | 504 | 318 | 675 | 1,473 | - | |
Market Cap Growth | 392.78% | 58.21% | -52.82% | -54.19% | - | - |
Enterprise Value | 2,269 | 484 | 286 | 632 | 1,489 | - |
Last Close Price | 2.39 | 0.53 | 0.34 | 0.70 | 1.43 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 17.38 | 22.21 | 72.59 | - |
PS Ratio | 23.13 | 5.12 | 1.92 | 3.92 | 7.35 | - |
PB Ratio | 9.79 | 1.95 | 1.15 | 2.27 | 5.00 | - |
P/TBV Ratio | 9.91 | 1.98 | 1.17 | 2.27 | 5.01 | - |
P/FCF Ratio | - | - | - | 396.54 | - | - |
P/OCF Ratio | - | 43.70 | 10.10 | 69.20 | 139.83 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 23.12 | 4.92 | 1.73 | 3.68 | 7.44 | - |
EV/EBITDA Ratio | - | - | 8.82 | 12.95 | 25.41 | - |
EV/EBIT Ratio | - | - | 11.24 | 14.83 | 27.63 | - |
EV/FCF Ratio | - | - | - | 371.79 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.06 | 0.07 | 0.08 | 0.10 | 0.12 |
Debt / EBITDA Ratio | - | - | 0.59 | 0.49 | 0.52 | 0.43 |
Debt / FCF Ratio | - | - | - | 14.15 | - | - |
Net Debt / Equity Ratio | -0.01 | -0.04 | -0.04 | -0.17 | -0.01 | 0.00 |
Net Debt / EBITDA Ratio | 0.04 | 1.12 | -0.33 | -1.05 | -0.05 | -0.01 |
Net Debt / FCF Ratio | - | 0.94 | 1.81 | -30.18 | 169.07 | 0.10 |
Asset Turnover | 0.31 | 0.31 | 0.51 | 0.49 | 0.67 | 1.18 |
Inventory Turnover | 4.12 | 6.10 | 7.36 | 5.38 | 6.87 | 7.92 |
Quick Ratio | 3.13 | 4.88 | 4.97 | 4.65 | 3.98 | 3.81 |
Current Ratio | 4.78 | 5.61 | 5.64 | 6.51 | 4.38 | 4.20 |
Return on Equity (ROE) | -31.17% | -12.16% | 6.58% | 10.52% | 8.64% | 17.68% |
Return on Assets (ROA) | -14.33% | -4.72% | 4.86% | 7.56% | 11.21% | 14.73% |
Return on Invested Capital (ROIC) | -31.41% | -9.16% | 6.70% | 11.60% | 13.84% | 20.04% |
Return on Capital Employed (ROCE) | -31.10% | -9.30% | 9.20% | 14.30% | 18.30% | 25.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.66% | -6.57% | 5.75% | 4.50% | 1.38% | - |
FCF Yield | - | -2.02% | -1.86% | 0.25% | -0.00% | - |
Dividend Yield | - | - | - | 3.02% | 1.47% | - |
Payout Ratio | - | - | 105.75% | 66.40% | - | - |
Buyback Yield / Dilution | 0.54% | 0.35% | 1.12% | -24.00% | -1.19% | - |
Total Shareholder Return | 0.54% | 0.35% | 1.12% | -20.98% | 0.28% | - |